Utilization of personalized tumor-specific methylation haplotypes of circulating DNA to monitor minimal residual disease in patients with hepatocellular carcinoma undergoing curative resection

被引：0
|
作者：
Yang, Xin-Rong
Guo, De-Zhen
Zhang, Shi-Yu
Xu, Min-Jie
Chen, Hua
Ma, Cheng-Cheng
Fu, Rui-Qing
Su, Ming-Yang
He, Qi-Ye
Zhang, Yun-Zhi
Su, Zhi-Xi
Liu, Rui
Fan, Jia
Zhou, Jian
机构：
[1] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Dept Liver Surg & Transplantat, Shanghai, Peoples R China
[2] Fudan Univ, Key Lab Carcinogenesis & Canc Invas, Minist Educ, Shanghai, Peoples R China
[3] Singlera Genom Ltd, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16245
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Circulating tumor DNA (ctDNA) as a minimal residual disease (MRD) assessment and recurrence risk in patients undergoing curative intent resection with or without adjuvant chemotherapy in colorectal cancer: A systematic review and meta-analysis.
    Chidharla, Anusha
    Rapoport, Eliot
    Agarwal, Kriti
    Linares, Brenda
    Chakrabarti, Sakti
    Kasi, Anup
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [22] Personalized circulating tumor DNA for minimal residual disease and dynamic assessment in patients undergoing neoadjuvant chemotherapy for breast cancer: Preliminary analysis from MSK-LINC
    Kim, Hong-Kyu
    An, Julia Ah-Reum
    Smith, Christopher Gareth
    Kim, Jisun
    Cabel, Luc
    Moiso, Enrico
    Ferraro, Emanuela
    Safonov, Anton
    Nelson, Konner
    Szuhany, Kathleen
    Drago, Joshua Z.
    Norton, Larry
    Xu, Amy
    Scher, Howard I.
    Chandarlapaty, Sarat
    Khan, Atif J.
    Li, Bob T.
    Robson, Mark E.
    Plitas, George
    Razavi, Pedram
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [23] Clinical validation of a novel circulating tumor DNA methylation assay for predicting recurrence of colorectal cancer in patients with curative-intent surgery by monitoring minimal residual disease.
    Kim, Jin-Soo
    Lee, Yun Young
    Kim, Young
    An, Joon
    Shin, Rumi
    Park, Jin Hyun
    Han, Jinil
    Choi, In Sil
    Heo, Seung Chul
    Moon, Youngho
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] Tumor-specific but not nonspecific cell-free circulating DNA can be used to monitor disease response in lymphoma
    Jones, Kimberley
    Nourse, Jamie P.
    Keane, Colm
    Crooks, Pauline
    Gottlieb, David
    Ritchie, David S.
    Gill, Devinder
    Gandhi, Maher K.
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (03) : 258 - 265
  • [25] Correlation of Circulating Angiogenic Factors with Circulating Tumor Cells and Disease Recurrence in Patients Undergoing Curative Resection for Colorectal Liver Metastases
    Nuh N. Rahbari
    Christoph Reissfelder
    Monika Mühlbayer
    Kathrin Weidmann
    Christoph Kahlert
    Markus W. Büchler
    Jürgen Weitz
    Moritz Koch
    Annals of Surgical Oncology, 2011, 18 : 2182 - 2191
  • [26] Correlation of Circulating Angiogenic Factors with Circulating Tumor Cells and Disease Recurrence in Patients Undergoing Curative Resection for Colorectal Liver Metastases
    Rahbari, Nuh N.
    Reissfelder, Christoph
    Muehlbayer, Monika
    Weidmann, Kathrin
    Kahlert, Christoph
    Buechler, Markus W.
    Weitz, Juergen
    Koch, Moritz
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (08) : 2182 - 2191
  • [27] Bespoke circulating tumor DNA assay for the detection of minimal residual disease in esophageal adenocarcinoma patients
    Ococks, E.
    Ng, A.
    Devonshire, G.
    Dashner, S.
    Chan, W-C.
    Sharma, S.
    Wu, H-T.
    Redmond, A.
    Northrop, A.
    Grehan, N.
    Sethi, H.
    Zimmermann, B.
    Smyth, E. C.
    Aleshin, A.
    Fitzgerald, R. C.
    ANNALS OF ONCOLOGY, 2020, 31 : S926 - S926
  • [28] Postoperative minimal residual disease to predict the risk of hepatocellular carcinoma (HCC) recurrence using plasma-only circulating tumor DNA assay
    Pan, Mingxin
    Cai, Jianpeng
    Xu, Yuyan
    Zhong, Kaihang
    Chen, Tingting
    CANCER RESEARCH, 2022, 82 (12)
  • [29] Circulating Tumor DNA Minimal Residual Disease Detection of Non-Small-Cell Lung Cancer Treated With Curative Intent
    Pellini, Bruna
    Chaudhuri, Aadel A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06) : 567 - +
  • [30] Detecting liquid remnants of solid tumors treated with curative intent: Circulating tumor DNA as a biomarker of minimal residual disease (Review)
    Chen, Huijuan
    Zhou, Qiming
    ONCOLOGY REPORTS, 2023, 49 (05)
12345